Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Putkonen, M
Right arrow Articles by Remes, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Putkonen, M
Right arrow Articles by Remes, K
Haematologica, Vol 90, Issue 4, 562-563
Copyright © 2005 by Ferrata Storti Foundation

Letter

Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patients

M Putkonen, A Rauhala, M Itala, M Kauppila, TT Pelliniemi, and K Remes

One hundred patients with newly diagnosed multiple myeloma (MM) were treated with high-dose chemotherapy followed by single or double autologous stem cell transplantation (ASCT). Up-front treatment with a double ASCT tended to prolong progression-free and overall survival.


This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
K.-S. Eom, C.-K. Min, S. Lee, Y.-J. Kim, S.-Y. Kim, H.-J. Kim, J.-W. Lee, W.-S. Min, and C.-C. Kim
Efficacy of Up-Front Treatment with a Double Stem Cell Transplantation in Multiple Myeloma
Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 432 - 438.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.